This work is licensed under a Creative Commons Attribution 4.0 International License.
Gradient4
General Information
DCTPep ID DCTPep02769
Peptide Name Gradient4
Sequence RVNAAIPNIIV
Sequence Length 11
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Membrane-targeted
Activity Information
| Cell Line | Disease | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|
| A549 | Lung adenocarcinoma | EC50>50 µM | MTT assay | 24 h | 1 |
| MCF-7 | Invasive breast carcinoma of no special type | EC50>50 µM | MTT assay | 24 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C53H94N16O14
Absent amino acids CDEFGHKLMQSTWY
Theoretical pI 9.75
Acidic residues 0
Basic residues 1
Polar residues 2
Molecular weight (Average) 1179.43
Molecular weight (Monoisotopic) 1178.71
Common amino acids I
Net charge 1
Instability index (II) 38.7
Aliphatic index 177.27
Grand average of hydropathicity (GRAVY) 1.127
Half Life
1 hours (mammalian reticulocytes, in vitro).
2 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 31375699
Title In silico design and optimization of selective membranolytic anticancer peptides
Doi 10.1038/s41598-019-47568-9
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.